Clinical Trials Directory

Trials / Unknown

UnknownNCT01745081

Comparison of 20% Mannitol and 3% Hypertonic Saline for Cerebral Relaxation During Elective Supratentorial Craniotomies

Comparison of the Efficacy Between 20% Mannitol and 3% Hypertonic Saline, Given as a Bolus at the Beginning of Elective Supratentorial Craniotomy for Tumor Resection, in Favoring Cerebral Relaxation Evaluated by a Sub-dural Intracranial Pressure Measurement.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Université de Sherbrooke · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Mannitol 20% has long been used to treat elevated intracranial hypertension in trauma and intensive care settings. More recent data indicate that hypertonic saline may be as effective or more effective than mannitol for this purpose, with possible fewer side effects. This study compares both agents in favoring cerebral relaxation during elective supratentorial procedures for tumor resection. Study hypothesis: 3% hypertonic saline will provide better cerebral relaxation with fewer side effects than 20% mannitol.

Conditions

Interventions

TypeNameDescription
DRUG20% mannitol bolus administration
DRUGHypertonic saline 3% bolus administration

Timeline

Start date
2012-09-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2012-12-07
Last updated
2012-12-07

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01745081. Inclusion in this directory is not an endorsement.